| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/26/2004 | WO2004016151A2 Pthrp-derived modulators of smooth muscle proliferation |
| 02/26/2004 | WO2004016083A1 Nonhuman animal reproducing pathogenic conditions of spinal and bulbar muscular atrophy and remedy for spinal and bulbar muscular atrophy |
| 02/26/2004 | WO2004016082A1 Nonhuman model animal nonresponsive to endotoxin and lipoprotein or lipopeptide |
| 02/26/2004 | WO2004016081A1 Method of expressing gene in transgenic birds using retrovirus vector and transgenic birds thus obtained |
| 02/26/2004 | WO2004016073A2 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/26/2004 | WO2004006891A3 Delivery system for pharmaceutical agents |
| 02/26/2004 | WO2004005335A3 Multimerised growth hormone fusion proteins |
| 02/26/2004 | WO2004003218A3 Antisense modulation of hypothetical protein loc51249 expression |
| 02/26/2004 | WO2004003009A3 Francisella tularensis immunogenic proteins and dna encoding these |
| 02/26/2004 | WO2004001376A3 Apparatus for polynucleotide detection and quantitation |
| 02/26/2004 | WO2004000881A9 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 02/26/2004 | WO2004000369A3 Method of magnetically manipulating a cell with magnetisable particles |
| 02/26/2004 | WO2003099204A3 Antisense modulation of inhibitor-kappa b kinase-beta expression |
| 02/26/2004 | WO2003098223A3 A method for killing cells by inhibiting histone activity in the cell |
| 02/26/2004 | WO2003097688A3 Muteins of placental growth factor type 1, preparation method and application thereof |
| 02/26/2004 | WO2003095674A3 Methods for evaluating a disease condition by detection of particle and non-particle bound nucleic acids in blood plasma and serum |
| 02/26/2004 | WO2003095652A3 Expression constructs for producing double-stranded (ds) rna and the use thereof |
| 02/26/2004 | WO2003091387A9 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 02/26/2004 | WO2003091311A8 Monomers containing polyoxyalkylenes and polymer supports therefrom |
| 02/26/2004 | WO2003089650A3 Allosteric nucleic acid sensor molecules |
| 02/26/2004 | WO2003089618A3 Transposon system and methods of use |
| 02/26/2004 | WO2003089589A3 Matrix analysis of gene expression in cells (magec) |
| 02/26/2004 | WO2003089578A3 Activation of equine oocytes |
| 02/26/2004 | WO2003087841A3 An ephrin-b receptor protein involved in carcinoma |
| 02/26/2004 | WO2003087345A3 Stimulation of nerve cell regeneration |
| 02/26/2004 | WO2003083435A3 Single primer isothermal nucleic acid amplification-enhanced analyte detection and quantification |
| 02/26/2004 | WO2003083117A3 Vascularization controlling gene |
| 02/26/2004 | WO2003083066A3 Methods for increasing polypeptide production |
| 02/26/2004 | WO2003083050A3 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog |
| 02/26/2004 | WO2003083037A3 Minimizing metal toxicity during electroporation enhanced delivery of polynucleotides |
| 02/26/2004 | WO2003078651A3 Novel hmga alleles and use of the same as genetic markers for growth, fatness, meat quality and feed efficiency traits |
| 02/26/2004 | WO2003073998A3 Local production and/or delivery of anti-cancer agents by stromal cell precursors |
| 02/26/2004 | WO2003073982A3 Anti-interleukin-1 beta analogs |
| 02/26/2004 | WO2003072758A3 Methods for designing oligo-probes with high hybridization efficiency and high antisense activity |
| 02/26/2004 | WO2003072745A3 Antigene locks and therapeutic uses thereof |
| 02/26/2004 | WO2003071270A3 Screening method |
| 02/26/2004 | WO2003070894A3 A non-invasive diagnostic test utilizing histone modification markers |
| 02/26/2004 | WO2003068926A3 Over-expression of extremozyme genes in pseudomonads and closely related bacteria |
| 02/26/2004 | WO2003068911A3 Citrus tristeza virus resistance genes and methods of use |
| 02/26/2004 | WO2003068908A3 Cardiotoxin molecular toxicology modeling |
| 02/26/2004 | WO2003066813A3 MINRs AS MODIFIERS OF INSULIN RECEPTOR SIGNALING AND METHODS OF USE |
| 02/26/2004 | WO2003064615A3 Amplifying repetitive nucleic acid sequences |
| 02/26/2004 | WO2003063765A3 Multi-disciplinary approach to validating or identifying targets using an in vivo system |
| 02/26/2004 | WO2003060152A3 Alteration of restriction endonuclease specificity by genetic selection |
| 02/26/2004 | WO2003060071A3 Albumin fusion proteins |
| 02/26/2004 | WO2003059934A3 Albumin fusion proteins |
| 02/26/2004 | WO2003058193A3 Microarrays for cell phenotyping and manipulation |
| 02/26/2004 | WO2003057914A3 METHOD FOR DETECTING HUMAN PAPILLOMAVIRUS mRNA |
| 02/26/2004 | WO2003057892A3 Viruses with enhanced lytic potency |
| 02/26/2004 | WO2003057846A3 Methods and materials for modulating task-3 |
| 02/26/2004 | WO2003057829A3 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 02/26/2004 | WO2003057822A3 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 02/26/2004 | WO2003054210B1 Regulated nucleic acid expression system |
| 02/26/2004 | WO2003054140A9 Phosphate limited inducible promoter and a bacillus expression system |
| 02/26/2004 | WO2003054019A3 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 02/26/2004 | WO2003052141A3 High troughput analysis and detection of multiple target sequences using circular probes |
| 02/26/2004 | WO2003052108A3 Improved methods and means for delivering inhibitory rna to plants and applications thereof |
| 02/26/2004 | WO2003050501A3 Indirect fluctuation screening |
| 02/26/2004 | WO2003048331A3 Antisense modulation of phospholipid scramblase 4 expression |
| 02/26/2004 | WO2003047420A3 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 02/26/2004 | WO2003046146A3 Compositions and methods of selective nucleic acid isolation |
| 02/26/2004 | WO2003039476A3 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874 |
| 02/26/2004 | WO2003039245A3 Transgenic mice knockout for histamine receptor h3 gene |
| 02/26/2004 | WO2003038058A3 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 02/26/2004 | WO2003037247A3 Methods and pharmaceutical compositions for dopaminergic modulation of t-cell adhesion and acitivty |
| 02/26/2004 | WO2003035840A3 69583 and 85924, novel human protein kinase family members and uses therefor |
| 02/26/2004 | WO2003035837A3 Novel compositions and methods for cancer |
| 02/26/2004 | WO2003034812A3 Aromatic methyltransferases and uses thereof |
| 02/26/2004 | WO2003033530A3 Mycobacterial antigens expressed under high oxygen tension |
| 02/26/2004 | WO2003029412A3 Restricted expression lentivial vectors |
| 02/26/2004 | WO2003029400A3 Cell lines for productive infection of hepatitis b virus |
| 02/26/2004 | WO2003028543A3 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease |
| 02/26/2004 | WO2003022212A3 Anti-tumor effects of prostate carcinoma tumor antigen-1 |
| 02/26/2004 | WO2003020892A3 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY |
| 02/26/2004 | WO2003016472A9 Hybrid interferon/interferon tau proteins, compositions and methods of use |
| 02/26/2004 | WO2003015708A3 Composition and method for treating hiv infection |
| 02/26/2004 | WO2003012148A3 Molecular vector for the genophenotypic characterisation of v3 sequences of hiv-1 gp120 |
| 02/26/2004 | WO2003012137A3 Methods for detecting parkinson's disease |
| 02/26/2004 | WO2003011899A3 Antigenic polypeptides |
| 02/26/2004 | WO2003010320A3 Recombinant vector derived from adeno-associated virus for gene therapy |
| 02/26/2004 | WO2003008449A8 Ntb-a, a surface molecule involved in natural killer cells activity |
| 02/26/2004 | WO2003006641A9 Epsti1, a gene induced by epithelial-stromal interaction in human breast cancer |
| 02/26/2004 | WO2003006485A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 02/26/2004 | WO2003005810A9 Cloned non-human mammals from contact inhibited donor cells |
| 02/26/2004 | WO2003004611A3 Human olfactory nucleotide-gated ion channels |
| 02/26/2004 | WO2003002711A3 A NOVEL GROUP OF α-AMYLASES AND A METHOD FOR IDENTIFICATION AND PRODUCTION OF NOVEL α-AMYLASES |
| 02/26/2004 | WO2002103050A3 Virus detection method, primers therefor and screening kit |
| 02/26/2004 | WO2002103014A3 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 02/26/2004 | WO2002103002A3 Gene associated with leishmania parasite virulence |
| 02/26/2004 | WO2002102973A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 02/26/2004 | WO2002101089A3 Method for specific, fast detection of threadlike bacteria |
| 02/26/2004 | WO2002101003A3 Stereoselective preparation of cyclic l-amino acids |
| 02/26/2004 | WO2002099047A3 PROMLs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 02/26/2004 | WO2002096928A3 Peptide vector for transferring molecules of interest to eurocaryotic cells |
| 02/26/2004 | WO2002095005A3 Therapeutic dna vaccination |
| 02/26/2004 | WO2002094992A3 Directed evolution of protein in mammalian cells |
| 02/26/2004 | WO2002092012A9 Compositions and methods for treating tumors bearing hmfg and cea antigens |
| 02/26/2004 | WO2002090506A3 Metabolite transporters |
| 02/26/2004 | WO2002088386A3 Nasba-based detection of fungi |
| 02/26/2004 | WO2002088378A3 66784, a novel human potassium channel and uses therefor |